Last Updated on January 8, 2024 by The Health Master
NPPA fixes retail price of 12 formulations
National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of three formulations under Drugs Prices Control Order (DPCO) – 2013 vide notification no. S. O. 95(E) dt 08-01-2021, relating to 82nd Authority meeting dated December 23, 2020.
To read / download the notification no. S. O. 95(E) dt 08-01-2021, click here
Name of the formulations are:
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Remogliflozin Etabonate + Metformin Hydrochloride Tablet | Each film coated tablet contains: Remogliflozin Etabonate 100mg, Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Glenmark Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd. | 11.44 |
2. | Remogliflozin Etabonate + Metformin Hydrochloride Tablet | Each film coated tablet contains: Remogliflozin Etabonate 100mg, Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Glenmark Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd. | 13.18 |
3. | Aceclofenac + Paracetamol Tablet | Each film coated tablet contains: Aceclofenac IP 100mg Paracetamol IP 325mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd. | 4.23 |
4. | Atorvastatin + Aspirin Capsule | Each Hard Gelatin Capsule Contains: Atorvastatin Calcium IP | 1 Capsule | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s | 2.59 |
eq to Atorvastatin 10mg (As Film coated tablet form) Aspirin IP 75mg (As Enteric Coated tablet form) | FDC Limited |
5. | Thiocolchicoside + Aceclofenac + Paracetamol Tablet | Each film coated tablet contains: Thiocolchicoside IP 4mg Aceclofenac IP 100mg Paracetamol IP 325mg | 1 Tablet | M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd. | 14.99 |
6. | Metformin Hydrochloride (As sustained release) and Vildagliptin Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP (As sustained release) 500mg, Vildagliptin 50mg, | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited | 6.58 |
7. | Metformin Hydrochloride (As sustained release) and Vildagliptin Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP (As sustained release) 1000mg, Vildagliptin 50mg, | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited | 7.07 |
8. | Metformin Hydrochloride (As sustained release) and Vildagliptin Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP (As sustained release) 500mg, Vildagliptin 50mg, | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Lupin Limited | 6.58 |
9. | Metformin Hydrochloride (As sustained release) and Vildagliptin Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP (As sustained release) 1000mg, Vildagliptin 50mg, | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Lupin Limited | 7.07 |
10. | Metronidazole and Dextrose Injection | Each 100ml contains: Metronidazole IP 0.2gm Dextrose IP (as anhydrous) 5.0gm Water for injection IP | Per 500ml Pack | M/s Aculife Healthcare Pvt. Ltd. | 79.29 |
11. | Dapagliflozin + Metformin Hydrochloride Extended-Release Tablet | Each film-coated tablet contains: Dapagliflozin 5mg, Metformin Hydrochloride IP (In Extended release | 1 Tablet | M/s Torrent Pharmaceuticals Limited | 6.97 |
form) 500mg | |||||
12. | Dapagliflozin + Metformin Hydrochloride Extended-Release Tablet | Each film-coated tablet contains: Dapagliflozin 5mg, Metformin Hydrochloride IP (In Extended release form) 1000mg | 1 Tablet | M/s Torrent Pharmaceuticals Limited | 8.35 |
The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a Price List in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
As per para 24(4) of DPCO 2013, every retailer and dealer shall display Price List and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
Also read other NPPA news, click here
The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
Follow and connect with us on Facebook and Linkedin
Go to main website, click here
Subscribe for daily free updates, click here